Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$9.60
$4.35
$11.97
$1.01B4.52528,025 shs1.43 million shs
Heska Co. stock logo
HSKA
Heska
$119.99
$119.09
$57.83
$120.03
$1.31B1.58241,932 shsN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$15.77
+1.7%
$14.89
$11.03
$21.22
$2.01B1.12911,953 shs600,952 shs
Instil Bio, Inc. stock logo
TIL
Instil Bio
$11.58
+3.1%
$11.24
$6.07
$13.46
$75.32M1.1724,912 shs54,819 shs
Vectrus, Inc. stock logo
VEC
Vectrus
$33.70
$30.69
$52.67
$388.40M1.159,814 shs756 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
Heska Co. stock logo
HSKA
Heska
0.00%0.00%0.00%0.00%+2.54%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
+2.45%+5.30%+1.84%+7.94%-21.12%
Instil Bio, Inc. stock logo
TIL
Instil Bio
-0.27%+0.09%+2.93%-3.19%-15.72%
Vectrus, Inc. stock logo
VEC
Vectrus
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/AN/AN/AN/AN/A
Heska Co. stock logo
HSKA
Heska
N/AN/AN/AN/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
3.2069 of 5 stars
4.42.00.00.02.32.50.6
Instil Bio, Inc. stock logo
TIL
Instil Bio
3.0415 of 5 stars
3.35.00.00.01.13.30.6
Vectrus, Inc. stock logo
VEC
Vectrus
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/A
Heska Co. stock logo
HSKA
Heska
N/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.82
Moderate Buy$19.7825.41% Upside
Instil Bio, Inc. stock logo
TIL
Instil Bio
2.67
Moderate Buy$36.00210.88% Upside
Vectrus, Inc. stock logo
VEC
Vectrus
N/AN/AN/AN/A

Current Analyst Ratings

Latest NEO, TIL, CNTTF, VEC, and HSKA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $21.00
5/1/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$21.00 ➝ $20.00
5/1/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
5/1/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$26.00
4/30/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$24.00 ➝ $19.00
4/12/2024
Instil Bio, Inc. stock logo
TIL
Instil Bio
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/25/2024
Instil Bio, Inc. stock logo
TIL
Instil Bio
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
2/26/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$18.00 ➝ $20.00
2/22/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$17.00 ➝ $19.00
2/21/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/21/2024
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$21.00 ➝ $24.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$15.96M0.00N/AN/AN/ANaN
Heska Co. stock logo
HSKA
Heska
$257.31M5.09$1.69 per share70.99$39.00 per share3.08
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$610.66M3.30$0.29 per share54.19$7.39 per share2.13
Instil Bio, Inc. stock logo
TIL
Instil Bio
N/AN/AN/AN/A$34.72 per shareN/A
Vectrus, Inc. stock logo
VEC
Vectrus
$1.78B0.00N/A5.21$29.85 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A$0.07137.180.00N/AN/AN/AN/AN/A
Heska Co. stock logo
HSKA
Heska
-$19.89M-$1.93N/A83.33N/A-7.86%0.94%0.67%N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$87.97M-$0.66N/AN/AN/A-13.79%-3.54%-1.99%8/13/2024 (Estimated)
Instil Bio, Inc. stock logo
TIL
Instil Bio
-$156.09M-$23.99N/AN/AN/AN/A-58.49%-41.58%N/A
Vectrus, Inc. stock logo
VEC
Vectrus
$45.73M$3.0910.630.00N/A2.02%15.76%6.07%N/A

Latest NEO, TIL, CNTTF, VEC, and HSKA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Instil Bio, Inc. stock logo
TIL
Instil Bio
N/A-$1.99-$1.99-$1.99N/AN/A
2/20/2024Q4 2023
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$0.07-$0.02+$0.05$0.07$152.90 million$155.55 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/AN/A
Heska Co. stock logo
HSKA
Heska
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
Instil Bio, Inc. stock logo
TIL
Instil Bio
N/AN/AN/AN/AN/A
Vectrus, Inc. stock logo
VEC
Vectrus
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/A
Heska Co. stock logo
HSKA
Heska
0.23
5.64
4.12
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.58
7.48
7.22
Instil Bio, Inc. stock logo
TIL
Instil Bio
0.36
15.23
15.22
Vectrus, Inc. stock logo
VEC
Vectrus
0.31
1.22
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.08%
Heska Co. stock logo
HSKA
Heska
99.01%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
Instil Bio, Inc. stock logo
TIL
Instil Bio
60.56%
Vectrus, Inc. stock logo
VEC
Vectrus
93.51%

Insider Ownership

CompanyInsider Ownership
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A
Heska Co. stock logo
HSKA
Heska
12.30%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
1.30%
Instil Bio, Inc. stock logo
TIL
Instil Bio
54.70%
Vectrus, Inc. stock logo
VEC
Vectrus
3.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A105.61 millionN/ANot Optionable
Heska Co. stock logo
HSKA
Heska
80810.91 million9.57 millionNot Optionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,100127.71 million126.05 millionOptionable
Instil Bio, Inc. stock logo
TIL
Instil Bio
496.50 million2.95 millionOptionable
Vectrus, Inc. stock logo
VEC
Vectrus
8,10011.83 million11.45 millionOptionable

NEO, TIL, CNTTF, VEC, and HSKA Headlines

SourceHeadline
Q1 2024 V2X Inc Earnings CallQ1 2024 V2X Inc Earnings Call
finance.yahoo.com - May 8 at 2:34 AM
Supplementary Review: V2X, Inc. (VVX), May 7, 2024Supplementary Review: V2X, Inc. (VVX), May 7, 2024
msn.com - May 7 at 4:32 PM
GAO US Navy Lawsuit: A Detailed Examination of the Cost Realism DisputeGAO US Navy Lawsuit: A Detailed Examination of the Cost Realism Dispute
usaherald.com - May 2 at 7:30 PM
V2X secures $75m to advance CBRN threat detection and responseV2X secures $75m to advance CBRN threat detection and response
msn.com - May 2 at 7:30 PM
V2X, Inc. (VVX) Q4 2023 Earnings Call TranscriptV2X, Inc. (VVX) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 7 at 11:01 AM
JMP Securities Reaffirms Their Buy Rating on V2X (VVX)JMP Securities Reaffirms Their Buy Rating on V2X (VVX)
markets.businessinsider.com - March 6 at 6:09 PM
Vectrus is about to announce earnings — heres what Wall Street expectsVectrus is about to announce earnings — here's what Wall Street expects
markets.businessinsider.com - March 4 at 12:03 PM
The Biggest Weapons Manufacturers in AmericaThe Biggest Weapons Manufacturers in America
msn.com - February 28 at 12:01 PM
Q4 2023 Dutch Bros Inc Earnings CallQ4 2023 Dutch Bros Inc Earnings Call
ca.finance.yahoo.com - February 22 at 8:32 AM
Deep Dive Into V2X Stock: Analyst Perspectives (4 Ratings)Deep Dive Into V2X Stock: Analyst Perspectives (4 Ratings)
markets.businessinsider.com - February 6 at 4:12 PM
V2X CEO Chuck Prow Nets 10th Wash100 Award as Company Reaches $1B RevenueV2X CEO Chuck Prow Nets 10th Wash100 Award as Company Reaches $1B Revenue
govconwire.com - February 5 at 10:18 AM
Navy Seeks Proposals for $2.7B Wireless & Telecommunications Services RecompeteNavy Seeks Proposals for $2.7B Wireless & Telecommunications Services Recompete
govconwire.com - February 2 at 9:29 AM
V2X CFO Shawn Mural Looking At Expansion Into New Markets & CapabilitiesV2X CFO Shawn Mural Looking At Expansion Into New Markets & Capabilities
govconwire.com - February 1 at 7:52 AM
Stifel Downgrades V2X (VVX)Stifel Downgrades V2X (VVX)
msn.com - January 6 at 7:47 AM
V2X awarded $190M Army contractV2X awarded $190M Army contract
virginiabusiness.com - January 4 at 5:57 PM
V2X wins $190M U.S. Army Contract to Enhance Warfighter Readiness in Middle East OperationsV2X wins $190M U.S. Army Contract to Enhance Warfighter Readiness in Middle East Operations
finance.yahoo.com - January 4 at 7:57 AM
Army decides to reset $100M IT services contractArmy decides to reset $100M IT services contract
washingtontechnology.com - November 20 at 6:03 PM
JMP Securities Initiates Coverage of V2X (VVX) with Market Outperform RecommendationJMP Securities Initiates Coverage of V2X (VVX) with Market Outperform Recommendation
msn.com - November 14 at 1:27 AM
Q3 2023 V2X Inc Earnings CallQ3 2023 V2X Inc Earnings Call
uk.finance.yahoo.com - November 7 at 1:51 AM
Supplementary Review: V2X, Inc. (VVX), November 6, 2023Supplementary Review: V2X, Inc. (VVX), November 6, 2023
msn.com - November 6 at 8:10 PM
Heres what Wall Street expects from Vectruss earningsHere's what Wall Street expects from Vectrus's earnings
markets.businessinsider.com - November 5 at 3:35 PM
How Cape Canaveral contractor taps into $1B pool for disaster responseHow Cape Canaveral contractor taps into $1B pool for disaster response
bizjournals.com - October 30 at 2:50 PM
The Biggest Weapons Manufacturer in AmericaThe Biggest Weapons Manufacturer in America
247wallst.com - October 21 at 12:27 PM
National Organization On Disability Announces 2023 Leading Disability EmployersNational Organization On Disability Announces 2023 Leading Disability Employers
inkfreenews.com - October 9 at 11:38 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CannTrust logo

CannTrust

OTCMKTS:CNTTF
CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.
Heska logo

Heska

NASDAQ:HSKA
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
NeoGenomics logo

NeoGenomics

NASDAQ:NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Instil Bio logo

Instil Bio

NASDAQ:TIL
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Vectrus logo

Vectrus

NYSE:VEC
Vectrus, Inc. provides facility and base operations, supply chain and logistics, information technology mission support, and engineering and digital integration services. It offers facility and base operations services, such as facilities operations and maintenance, security, base life support, facilities engineering and management, airfield management, civil engineering, public works, transportation operations, and emergency services. The company also offers supply chain and logistics services, including warehouse management and distribution, asset management and logistics, integrated logistics, supply chain as a service, full spectrum aviation maintenance, repair and overhaul, and equipment maintenance, repair, and services. Additionally, it provides information technology mission support services comprising communications, management and service support, IT service management design and implementation, network and cybersecurity, systems installation and activation, and mission support. Further, the company offers engineering and digital integration solutions, such as perimeter security and intrusion detection, integrated electronic security monitoring and video management systems, systematic integrated security protection of physical assets, IP and computer systems, design and training, system-of-systems engineering and software development, advanced engineering, sensor and visualization technologies, energy solutions, and electromagnetic interoperability. Vectrus, Inc. was incorporated in 2014 and is headquartered in Colorado Springs, Colorado.